Table 1. Mutation analysis of VDJ region in Mef−/− Rad50s/s plasma cell tumor samples.
Mice UID | Tumor | VH | DH | JH | No.Mutationsat VH | Mutations atVH andAmion Acid Changes | Percent Mutationsat VH |
---|---|---|---|---|---|---|---|
33 | MM | IGHV1-50*01, IGHV1-59*01 or IGHV1S40*01 | IGHD2-3*01 | IGHJ4*01 | 1 | c227 > g, A76 > G | 1.0 |
112 | MM | IGHV1-67*01 | IGHD4-1*01 | IGHJ3*01 | 2 | c227 > g, A76 > G a232 > t, M78 > L | 2.1 |
217 | PCT | IGHV1-67*01 | IGHD3-2*02 | IGHJ3*01 | 7 | c227 > g, A76 > G | 7.3 |
a232 > t, M78 > L | |||||||
g25 > c, S85 > T | |||||||
a256 > t, T86 > S | |||||||
a263 > t, Y88 > F | |||||||
a290 > g, E97 > G | |||||||
g291 > a, E97 > G |
The first two columns show mouse UID and the phenotype of the mice (MM, multiple myeloma; PCT, solitary plasmacytoma). The VH, DH, and JH usage and mutations were scored by comparing each sequence with the germline sequences at the IMGT server.